Sponsor Pipeline

Janux Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
8
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT07545811
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer		 Trial sites expanded: 1 -> 4 locations
Active Trials by Phase
Phase 1
3
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07545811 Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer Prostate Cancer Recruiting
NCT05519449 Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer… Prostate Cancer Recruiting
NCT05783622 Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies Non-Small Cell Lung Cancer Active, Not Recruiting
Early Phase 1
NCT07291323 Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability. Autoimmune Recruiting
Disease Areas
Prostate Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Pancreatic Cancer (1) Kidney Cancer (1)
Get alerts when Janux Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free